Smith, Salley & Associates Becton Dickinson & CO Transaction History

Smith, Salley & Associates

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 10, 2022	SELL	$230.08 - $250.94 $750,290 - $818,315	-3,261 Closed	0 $0
Q3 2021 Nov 05, 2021	BUY	$232.72 - $256.47 $58,878 - $64,886	253 Added 8.41%	3,261 $802,000
Q2 2021 Aug 09, 2021	BUY	$232.65 - $254.58 $77,007 - $84,265	331 Added 12.36%	3,008 $732,000
Q1 2021 Apr 30, 2021	SELL	$232.09 - $256.88 $5,338 - $5,908	-23 Reduced 0.85%	2,677 $651,000
Q4 2020 Jan 28, 2021	BUY	$221.92 - $245.94 $134,039 - $148,547	604 Added 28.82%	2,700 $676,000
Q3 2020 Nov 05, 2020	BUY	$215.77 - $276.76 $7,767 - $9,963	36 Added 1.75%	2,096 $488,000
Q2 2020 Aug 04, 2020	BUY	$219.9 - $263.41 $51,676 - $61,901	235 Added 12.88%	2,060 $493,000
Q1 2020 Apr 24, 2020	BUY	$195.69 - $279.01 $167,314 - $238,553	855 Added 88.14%	1,825 $419,000
Q4 2019 Jan 27, 2020	BUY	$236.45 - $266.82 $17,024 - $19,211	72 Added 8.02%	970 $264,000
Q3 2019 Oct 30, 2019	BUY	$230.58 - $256.08 $17,985 - $19,974	78 Added 9.51%	898 $227,000
Q2 2019 Jul 12, 2019	BUY	$217.4 - $246.08 $178,268 - $201,785	820 New	820 $207,000

1,737

250M

690K

787K

Ticker BDX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 285,195,008
Market Cap $63.3B
Description
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...

Get notified when there are updates to the investment portfolio of Smith, Salley & Associates, based on Form 13F filings with the SEC.

Stay updated on Smith, Salley & Associates with notifications on news.